Companies · Healthtech

NRS Health & Wellness GP LLC

NEW YORK · Healthtech · refined from filed group “Other

Diligence memoA one-page analyst read on NRS Health & Wellness GP LLC — recommendation, valuation, rhythm, risks.
$32.8M
Total raised · real
1
Rounds
0.3×
Latest step-up
Top 15%
Sector rank · raised
Series B
Latest stage · inferred · Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

NRS Health & Wellness GP LLC looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.55× the median modeled value of Series B Healthtech companies in 2016–2018 (33 peers) — value vs value, same stage and era.
Dormant
  • Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

NRS Health & Wellness GP LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
8.1 yr record
Peak capital year was 2018 with $47.6M across 3 filings.
Market position
ahead of 86% of Healthtech peers
Capital scale is ahead of 86% of Healthtech peers; modeled value is above 96% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2018: $47.6M across 3 filings.
  • Largest single filing was $32.8M on 2018-06-01.
  • Filing rows sum to $47.6M, while canonical raised total is $32.8M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

NRS Health & Wellness GP LLC is one of 2138 Healthtech companies tracked from NEW YORK. By capital raised it ranks in the upper tier (ahead of 86% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
5
Investors (latest)
2015
Year incorporated
2018-06-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2018-06-01 Raised $33M (real) Modeled valuation $813M (est)$33M$813MSeries B2018Series A · 2018-06-01 Raised $11M (real) Modeled valuation $255M (est)$11M$255MSeries A2018Seed · 2018-06-01 Raised $3.5M (real) Modeled valuation $97M (est)$3.5M$97MSeed2018+$11M+$3.5MCumulative $48M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$32.8M · 2018
Bridge · Series B-stage$11.3M · 2018smaller follow-on
Bridge · Series B-stage$3.5M · 2018smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$813.0M
Base estimate est.
$77.1M
Conservative case
$3.1B
Upside case
$182.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $813.0M · 2018-06-012018Series A · modeled $255.2M · 2018-06-01Seed · modeled $97.0M · 2018-06-012018
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
6.0 yr
Elapsed time used
8.1 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
8.1 yr
On record since
2018
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.4× above median
This company$32.8M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.2× of median
This company$3.5M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 24× above median
This company$813.0M
Sector median$33.8M

Raised more than 86% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #3 of 33.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0MCapital raised (log)Altimate Medical Holdings, Inc. · Series B Raised $40.0M · modeled $991.3M (est)Southeast Healthcare Partners II, LLC · Series B Raised $34.0M · modeled $842.6M (est)Aspire Health, Inc. · Series B Raised $49.9M · modeled $776.9M (est)Uprising Health LLC · Series B Raised $30.5M · modeled $756.9M (est)OODA Health, Inc. · Series B Raised $30.5M · modeled $755.9M (est)Provision Healthcare, LLC · Series B Raised $30.4M · modeled $752.2M (est)Limelight Health, Inc. · Series B Raised $40.2M · modeled $743.5M (est)Cc Dental Implants Holding, Llc · Series B Raised $27.0M · modeled $669.6M (est)Inari Medical, Inc. · Series B Raised $51.9M · modeled $669.2M (est)HealthReveal, Inc. · Series B Raised $26.6M · modeled $659.2M (est)Global Wellness International, Inc. · Series B Raised $25.0M · modeled $619.6M (est)NRS Health & Wellness GP LLC (this company) Raised $32.8M · modeled $813.0M (est)NRS Health & Wellness GP LLC
CompanyStageRaised · realValue · estvs peer med.
Altimate Medical Holdings, Inc.Series B$40.0M$991.3M1.89×
Southeast Healthcare Partners II, LLCSeries B$34.0M$842.6M1.60×
NRS Health & Wellness GP LLC this companySeries B$32.8M$813.0M1.55×
Aspire Health, Inc.Series B$49.9M$776.9M1.48×
Uprising Health LLCSeries B$30.5M$756.9M1.44×
OODA Health, Inc.Series B$30.5M$755.9M1.44×
Provision Healthcare, LLCSeries B$30.4M$752.2M1.43×
Limelight Health, Inc.Series B$40.2M$743.5M1.41×
Cc Dental Implants Holding, LlcSeries B$27.0M$669.6M1.27×
Inari Medical, Inc.Series B$51.9M$669.2M1.27×
HealthReveal, Inc.Series B$26.6M$659.2M1.25×
Global Wellness International, Inc.Series B$25.0M$619.6M1.18×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$32.8M2018-06-01$182.2M$813.0M90%
Series A$11.3M2018-06-01$51.4M$255.2M90%
Seed$3.5M2018-06-01$17.5M$97.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$32.8M2018-06-01
    • First recorded raise — entered as Series B.
    • 17 investors on this round.
  2. Series A$11.3M2018-06-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× smaller than the prior — bridge or down round.
    • 16 investors on this round.
  3. Seed$3.5M2018-06-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.2× smaller than the prior — bridge or down round.
    • 5 investors on this round.
Intelligence
Modeled next raise
$3.5M
Modeled next size est.range $3.5M$5.6M
0.3×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Charles H. Columbus2018-06
Eli Mor2018-06
Sam Salman2018-06
Registry & provenance

NRS Health & Wellness GP LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1733549
SEC CIK
2015
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Vivante Health, Inc.HealthtechSeries B$32.6M$281.0Msame sector · same stage
Sibel Health Inc.HealthtechSeries B$33.0M$326.5Msame sector · same stage
RightSite Health, Inc.HealthtechSeries B$33.6M$115.1Msame sector · same stage
Southeast Healthcare Partners II, LLCHealthtechSeries B$34.0M$842.6Msame sector · same stage
Pipeline Health Holdings LLCHealthtechSeries B$31.6M$381.0Msame sector · same stage
Stride Health, Inc.HealthtechSeries B$34.5M$272.6Msame sector · same stage
Keystone Dental Holdings, Inc.HealthtechSeries B$34.7M$424.9Msame sector · same stage
Healthy America, LLCHealthtechSeries B$31.0M$435.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Wellness Natural Inc.HealthtechSeed$66.4M82%
Wellness Coaches Usa, LlcHealthtechSeries A$73.3M82%
Nature's Care & Wellness, LLCHealthtechPre-Seed$29.0M81%
Standard Wellness Company, LlcHealthtechSeed$91.5M80%
Wellness Way LLCHealthtechSeed$3.0M80%
Wellness Awareness, LLCHealthtechPre-Seed$8.6M80%
Neb Health IncHealthtechSeed$51.4M80%
Basis Medical, LLCHealthtechPre-Seed$1.2M80%
Frequently asked
How much funding has NRS Health & Wellness GP LLC raised?
NRS Health & Wellness GP LLC has raised approximately $32.8M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is NRS Health & Wellness GP LLC's estimated valuation?
Provath's modeled valuation for NRS Health & Wellness GP LLC is approximately $813.0M (modeled range $77.1M–$3.1B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is NRS Health & Wellness GP LLC at?
NRS Health & Wellness GP LLC's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Jun 01.
What does NRS Health & Wellness GP LLC do and where is it based?
NRS Health & Wellness GP LLC operates in the Healthtech sector, based in NEW YORK.
Explore related

See where NRS Health & Wellness GP LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at NRS Health & Wellness GP LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.